FGF2 amplification rather than FGFR1 amplification may be the predominant mechanism for increased FGFR1 signalling as it correlated with higher PD-L1 expression in human lung squamous cell carcinoma and urothelial cancers [101,102]. This evidence concerns the gene FGFR1 and squamous cell lung carcinoma.